As illustrated in Figure 8, the data in the present study are consistent with a model in which BRAF V600E-activated MAPK pathway causes hypomethylation of the WIPF1 promoter, hence resulting in over-expression of WIPF1, which in turn promotes the invasiveness and aggressiveness of thyroid cancer. This evidence concerns the gene WIPF1 and thyroid gland carcinoma.